455B.501 - REGULATION OF INFECTIOUS WASTE.

        455B.501  REGULATION OF INFECTIOUS WASTE.         1.  As used in this section, unless the context otherwise      requires:         a.  "Contaminated animal carcasses" means waste including      carcasses, body parts, and bedding of animals that were exposed to      infectious agents during research, production of biologicals, or      testing of pharmaceuticals.         b.  "Contaminated sharps" means all discarded sharp items      derived from patient care in medical, research, or industrial      facilities including glass vials containing materials defined as      infectious, hypodermic needles, scalpel blades, and pasteur pipettes.         c.  "Cultures and stocks of infectious agents" means specimen      cultures collected from medical and pathological laboratories,      cultures and stocks of infectious agents from research and industrial      laboratories, wastes from the production of biological agents,      discarded live and attenuated vaccines, and culture dishes and      devices used to transfer, inoculate, or mix cultures.         d.  "Human blood and blood products" means human serum,      plasma, other blood components, bulk blood, or containerized blood in      quantities greater than twenty milliliters.         e.  "Infectious" means containing pathogens with sufficient      virulence and quantity so that exposure to an infectious agent by a      susceptible host could result in an infectious disease when the      infectious agent is improperly treated, stored, transplanted, or      disposed.         f.  "Infectious waste" means waste, which is infectious,      including but not limited to contaminated sharps, cultures, and      stocks of infectious agents, blood and blood products, pathological      waste, and contaminated animal carcasses from hospitals or research      laboratories.         g.  "Pathological waste" means human tissues and body parts      that are removed during surgery or autopsy.         2.  The department shall recommend, for adoption by the      commission, standards for on-site and off-site treatment of      infectious waste.  In developing standards, the department shall      consider factors affecting the feasibility of alternative methods of      treatment and disposal, including but not limited to the volume of      infectious waste generated, the availability of treatment facilities      within geographic areas, and the costs of transporting infectious      wastes to treatment facilities.  The standards shall include      monitoring requirements for treatment facilities and training      requirements for operators of facilities.  The standards may include      requirements for management plans dealing with the plans for      management of infectious wastes in compliance with adopted standards.      In cases in which an individual generator of infectious waste is      served by a person treating or disposing of the infectious waste, the      person treating or disposing of the waste may prepare the plan for      all generators served.  
         Section History: Recent Form
         89 Acts, ch 245, § 1; 99 Acts, ch 46, §1         Local approval of infectious waste incinerator projects; §      455B.305A